An interesting study to be conducted could be the investigation of GAL-3 binding preference to ABO blood group in relation to clinical outcome in SCA, since the N-acetylgalactosamine is the principal antigen on erythrocytes of A blood group. This evidence concerns the gene LGALS3 and autosomal dominant cerebellar ataxia.